SAScion Asset Management, LLC
Institutional investor · Portfolio as of Q2 2025
Top Holdings15 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
UNITEDHEALTH GROUP INC | 350,000 | $109.2M | 18.9% | — | — | — | New — |
REGENERON PHARMACEUTICALS | 200,000 | $105M | 18.2% | — | — | — | New — |
LULULEMON ATHLETICA INC | 400,000 | $95M | 16.4% | — | — | — | New — |
META PLATFORMS INC-CLASS A | 100,000 | $73.8M | 12.8% | — | — | — | New — |
ESTEE LAUDER COMPANIES-CL A | 500,000 | $40.4M | 7.0% | — | — | — | New — |
JD.COM INC-ADR | 1M | $32.6M | 5.6% | — | — | — | New — |
ALIBABA GROUP HOLDING-SP ADR | 250,000 | $28.4M | 4.9% | — | — | — | New — |
ASML HOLDING NV-NY REG SHS | 25,000 | $20M | 3.5% | — | — | — | New — |
V F CORP | 1.5M | $17.6M | 3.0% | — | — | — | New — |
ESTEE LAUDER COMPANIES-CL A | 150,000 | $12.1M | 2.1% | $68.75 | +25.24% | 3 qtrssince 2024-Q4 | Decreased 0 |
LULULEMON ATHLETICA INC | 50,000 | $11.9M | 2.1% | $235.02 | 0.00% | 1 qtr | New 75 |
BRUKER CORP | 250,000 | $10.3M | 1.8% | $41.69 | 0.00% | 1 qtr | New 66 |
REGENERON PHARMACEUTICALS | 15,000 | $7.9M | 1.4% | $519.56 | +54.65% | 1 qtr | New 66 |
MERCADOLIBRE INC | 3,000 | $7.8M | 1.4% | $2,560.05 | -27.95% | 1 qtr | New 66 |
UNITEDHEALTH GROUP INC | 20,000 | $6.2M | 1.1% | $305.12 | +31.66% | 1 qtr | New 65 |
Scion Asset Management, LLC manages $578.3M across 15 positions as of Q2 2025. Top holdings: UNH (18.9%), REGN (18.2%), LULU (16.4%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 1/5.0.
Added 5 new positions, trimmed 1. Top move: LULU (NEW, conviction 75). Portfolio: $578M across 15 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Last filed Q3 2025 - no longer filing.
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer